Federal Data Hub › HRSA 340B · JSON
Hemophilia Treatment Program (CC) · 340B ID HM18103
ParticipatingHemophilia Treatment Center
Lehigh Valley Hospital is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in Allentown, PA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 17 contract-pharmacy arrangement(s) (15 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ACCREDO HEALTH GROUP INC | TEMPE, AZ | 2022-01-01 | — | 75292 |
| ACCREDO HEALTH GROUP INC | WARRENDALE, PA | 2022-01-01 | — | 23041 |
| ACCREDO HEALTH GROUP INC | MEMPHIS, TN | 2022-01-01 | — | 45979 |
| ACCREDO HEALTH GROUP, INC. | NEWARK, DE | 2022-01-01 | — | 98337 |
| ACCREDO HEALTH GROUP, INC. | ORLANDO, FL | 2022-01-01 | — | 39194 |
| ACCREDO HEALTH GROUP, INC. | INDIANAPOLIS, IN | 2022-01-01 | — | 51763 |
| ACCREDO HEALTH GROUP, INC. | LENEXA, KS | 2022-01-01 | — | 62883 |
| ACCREDO HEALTH GROUP, INC. | PINE BROOK, NJ | 2022-01-01 | — | 16515 |
| OPTUM INFUSION SERVICES 101, INC. | FARMINGDALE, NY | 2022-07-27 | — | 21203 |
| OPTUM INFUSION SERVICES 201, INC. | OVIEDO, FL | 2022-07-01 | — | 39217 |
| OPTUM INFUSION SERVICES 305, LLC | LENEXA, KS | 2022-07-01 | — | 62882 |
| OPTUM INFUSION SERVICES 305, LLC | PLYMOUTH MEETING, PA | 2022-07-01 | — | 25467 |
| OPTUM INFUSION SERVICES 500, INC. | IRWINDALE, CA | 2022-07-01 | 2022-07-06 | 120225 |
| OPTUM INFUSION SERVICES 500, INC. | WALLINGFORD, CT | 2022-07-27 | — | 122415 |
| OPTUM INFUSION SERVICES 550, LLC | WOBURN, MA | 2022-07-27 | — | 13688 |
| OPTUM INFUSION SERVICES 550, LLC | CINCINNATI, OH | 2022-07-01 | — | 50817 |
| OPTUM INFUSION SERVICES 551, LLC | WINDSOR, CT | 2022-07-01 | 2022-07-06 | 91178 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.